Prevalence of inapropriate LDL cholesterol levels in patients with coronary disease and/or type 2 diabetes

被引:26
|
作者
Perez de Isla, L. [1 ]
Saltijeral Cerezo, A. [2 ]
Vitale, G. [3 ]
Gonzalez Timon, B. [3 ]
Torres Do Rego, A. [4 ]
Alvarez-Sala Walther, L. A. [4 ]
机构
[1] Hosp Clin San Carlos, Serv Cardiol, Madrid, Spain
[2] Hosp Tajo, Serv Cardiol, Madrid, Spain
[3] MSD Espana, Dept Med Merck Sharp & Dohme, Madrid, Spain
[4] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Unidad Riesgo Cardiovasc & Lipidos, Inst Invest Sanitarias,Fac Med,Red RECAVA, Madrid, Spain
来源
REVISTA CLINICA ESPANOLA | 2012年 / 212卷 / 10期
关键词
Hypercholesterolaemia; Cardiovascular risk factors; Metabolic syndrome; Cardiovascular risk control; HIGH-DENSITY-LIPOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; RISK-FACTORS; SECONDARY PREVENTION; MORTALITY;
D O I
10.1016/j.rce.2012.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Clinical practice guidelines recommend achieving concentrations of LDL cholesterol less than 100 mg/dl (and in some cases less than 70 mg/dl) in patients with coronary artery disease and/or diabetes mellitus type 2 (DM2). We have examined the compliance with these objectives in patients treated in Spain with these conditions. Methods: Cross-sectional epidemiological study. Data were obtained during the visit of the study or, in their absence, based on data contained in the medical record by 874 doctors of the 17 autonomous communities in Spain. Demographic information, risk factors, cardiovascular and prescribed treatments were collected. Results: In the final analysis 6.988 (62.7% male) patients were included. 2586 (37%) had coronary disease, 2654 (38%) DM2 and 1748 (25%) both conditions. 65% had metabolic syndrome. Vascular risk factors median number was 4. 57% and 86% showed a concentration of LDL cholesterol > 100 and >70 mg/dl respectively. The proportion patients with LDL concentration >100 mg/dl was 4% greater in the DM2 (62.4%) than in coronary patients (57.1%; p 0.0001). Concentration of triglycerides > 150 mg/dl was higher in patients with DM2 (50.5%) than in coronary patients (43.5%; p 0.0001). The proportion of patients with LDL > 70 mg/dl was similar in the coronary group and in the DM2 Group (88.4% and 87.0%, respectively). More than half of patients with coronary heart disease (57.5%) or DM2 (55.7%) showed inadequate levels of HDL (< 40 mg/dl men; <50 mg/dl women). Conclusions: More than a half of patients with diabetes mellitus and/or coronary artery disease enrolled in the CODIMET study do not achieve the recommended LDL cholesterol target for high cardiovascular risk patients. (c) 2012 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 50 条
  • [41] Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels
    Chen, Qin-Fen
    Cao, Dan
    Ye, Ting-Ting
    Deng, Hui-Hui
    Zhu, Hong
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [42] Relation of asymmetrical dimethylarginine levels with renal outcomes in hypertensive patients with and without type 2 diabetes mellitus
    Triches, Cristina B.
    Quinto, Marie
    Mayer, Saurus
    Batista, Marcelo
    Zanella, Maria Teresa
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (03) : 316 - 320
  • [43] Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
    Byrkjeland, Rune
    Edvardsen, Elisabeth
    Njerve, Ida Unhammer
    Arnesen, Harald
    Seljeflot, Ingebjorg
    Solheim, Svein
    DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [44] Nonfasting Apo-lipoprotein B & Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
    Nayyer-uz-Zaman
    Dar, Muhammad Habeel
    Adnan, Yasir
    Noor, Lubna
    Naz, Gul
    Zahoor
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2018, 34 (02) : 247 - 252
  • [45] Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study
    Ferrannini, Giulia
    Manca, Maria Laura
    Magnoni, Marco
    Andreotti, Felicita
    Andreini, Daniele
    Latini, Roberto
    Maseri, Attilio
    Maggioni, Aldo P.
    Ostroff, Rachel M.
    Williams, Stephen A.
    Ferrannini, Ele
    DIABETES CARE, 2020, 43 (04) : 843 - 851
  • [46] METABOLIC SYNDROME COMPONENTS AND PREVALENCE OF CARDIOVASCULAR DISEASE AMONG TYPE 2 DIABETIC PATIENTS IN MALAYSIA
    Tan, Mun Chieng
    Wong, Teck Wee
    Ng, Ooi Chuan
    Joseph, Anthony
    Hejar, Abdul Rahman
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 45 (01) : 226 - 235
  • [47] Type 2 diabetes and cardiovascular disease in South Asians
    Gholap, Nitin
    Davies, Melanie
    Patel, Kiran
    Sattar, Naveed
    Khunti, Kamlesh
    PRIMARY CARE DIABETES, 2011, 5 (01) : 45 - 56
  • [48] Effect of atorvastatin on non-cholesterol sterols in patients with type 2 diabetes mellitus and cardiovascular disease
    Smahelová, A
    Hyspler, R
    Haas, T
    Tichá, A
    Bláha, V
    Zadák, Z
    PHARMACOLOGICAL RESEARCH, 2005, 51 (01) : 31 - 36
  • [49] Changing Cholesterol Levels and Coronary Heart Disease Risk
    Wilson, Peter W. F.
    CIRCULATION, 2016, 133 (03) : 239 - 241
  • [50] The changes in achievement of target LDL-cholesterol levels between 2006 and 2017 in Czech patients with chronic coronary heart disease
    Vorlickova, Pavla
    Mayer, Otto, Jr.
    Bruthans, Jan
    Seidlerova, Jitka
    Gelzinsky, Julius
    Materankova, Marketa
    Cvicela, Martina
    Cifkova, Renata
    Filipovsky, Jan
    COR ET VASA, 2019, 61 (01) : E20 - E26